Omega Healthcare Investors (NYSE:OHI) Issues Quarterly Earnings Results

Omega Healthcare Investors (NYSE:OHI – Get Free Report) announced its earnings results on Tuesday. The real estate investment trust reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.20), FiscalAI reports. The business had revenue of $340.55 million for the quarter, compared to the consensus estimate of $269.16 million. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The business’s quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.79 EPS.

Omega Healthcare Investors Trading Up 1.3%

Shares of NYSE OHI opened at $47.60 on Wednesday. The firm has a 50 day moving average of $46.18 and a 200 day moving average of $46.63. The firm has a market capitalization of $14.42 billion, a price-to-earnings ratio of 17.00, a price-to-earnings-growth ratio of 1.90 and a beta of 0.56. Omega Healthcare Investors has a 12-month low of $41.53 and a 12-month high of $52.39.

Omega Healthcare Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Thursday, November 5th will be issued a $0.68 dividend. The ex-dividend date of this dividend is Thursday, November 5th. This represents a $2.72 dividend on an annualized basis and a dividend yield of 5.7%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 97.14%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on OHI shares. Mizuho upped their price objective on shares of Omega Healthcare Investors from $45.00 to $46.00 and gave the stock a “neutral” rating in a report on Monday, August 31st. Wall Street Zen upgraded shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research note on Saturday, October 17th. Citizens Jmp raised shares of Omega Healthcare Investors from a “market perform” rating to a “market outperform” rating and set a $52.00 target price for the company in a research report on Thursday, October 22nd. Wells Fargo & Company decreased their target price on shares of Omega Healthcare Investors from $48.00 to $46.00 and set an “equal weight” rating for the company in a research note on Monday, October 19th. Finally, Weiss Ratings reissued a “buy (b+)” rating on shares of Omega Healthcare Investors in a report on Friday, September 25th. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $49.93.

View Our Latest Research Report on OHI

Key Stories Impacting Omega Healthcare Investors

Here are the key news stories impacting Omega Healthcare Investors this week:

About Omega Healthcare Investors

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust focused on the healthcare sector. The company invests in and owns healthcare facilities, with a primary emphasis on skilled nursing and assisted living properties.

Omega generally leases its properties to healthcare operators under long-term agreements, supporting services for seniors and individuals who require post-acute, rehabilitative, or long-term care. Its portfolio has also included other healthcare-related properties, such as continuing care retirement communities and specialty facilities.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega serves healthcare operators across the United States and the United Kingdom.

Featured Stories

Earnings History for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.